Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion Receives $1M in Settlement; Moves to Nasdaq Capital Market
February 14, 2012
Vermillion Receives $1M in Settlement; Moves to Nasdaq Capital Market
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Nasdaq Extends Deadline for CombiMatrix to Meet Listing Requirement
May 30, 2013 / GenomeWeb Daily News
Vermillion Sends Quest Notice of Default Alleging Breach of Strategic Alliance Agreement
May 24, 2013 / ProteoMonitor
BG Medicine Fails to Meet Listing Requirement, Nasdaq Warns Firm
May 20, 2013 / GenomeWeb Daily News
Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News